| Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial CM Nutting, JP Morden, KJ Harrington, TG Urbano, SA Bhide, C Clark, ... The lancet oncology 12 (2), 127-136, 2011 | 1838 | 2011 |
| Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019 | 903 | 2019 |
| Volumetric modulated arc therapy: a review of current literature and clinical use in practice M Teoh, CH Clark, K Wood, S Whitaker, A Nisbet The British journal of radiology 84 (1007), 967-996, 2011 | 891 | 2011 |
| Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial D Dearnaley, I Syndikus, G Sumo, M Bidmead, D Bloomfield, C Clark, ... The lancet oncology 13 (1), 43-54, 2012 | 366 | 2012 |
| A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems M Hussein, P Rowshanfarzad, MA Ebert, A Nisbet, CH Clark Radiotherapy and Oncology 109 (3), 370-376, 2013 | 193 | 2013 |
| Challenges in calculation of the gamma index in radiotherapy–towards good practice M Hussein, CH Clark, A Nisbet Physica Medica 36, 1-11, 2017 | 187 | 2017 |
| Tissue mimicking materials for imaging and therapy phantoms: a review CK McGarry, LJ Grattan, AM Ivory, F Leek, GP Liney, Y Liu, P Miloro, ... Physics in Medicine & Biology 65 (23), 23TR01, 2020 | 146 | 2020 |
| The impact of introducing intensity modulated radiotherapy into routine clinical practice EA Miles, CH Clark, MTG Urbano, M Bidmead, DP Dearnaley, ... Radiotherapy and oncology 77 (3), 241-246, 2005 | 140 | 2005 |
| Evaluation of Gafchromic EBT-XD film, with comparison to EBT3 film, and application in high dose radiotherapy verification AL Palmer, A Dimitriadis, A Nisbet, CH Clark Physics in Medicine & Biology 60 (22), 8741, 2015 | 115 | 2015 |
| Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial SL Gulliford, AB Miah, S Brennan, D McQuaid, CH Clark, M Partridge, ... Radiotherapy and oncology 104 (2), 205-212, 2012 | 95 | 2012 |
| A critical evaluation of the PTW 2D‐ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification M Hussein, EJ Adams, TJ Jordan, CH Clark, A Nisbet Journal of applied clinical medical physics 14 (6), 274-292, 2013 | 83 | 2013 |
| Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials CH Clark, EGA Aird, S Bolton, EA Miles, A Nisbet, JAD Snaith, ... The British journal of radiology 88 (1055), 20150251, 2015 | 82 | 2015 |
| Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx CH Clark, AM Bidmead, CD Mubata, KJ Harrington, CM Nutting Radiotherapy and oncology 70 (2), 189-198, 2004 | 81 | 2004 |
| PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised … CM Nutting, JP Morden, KJ Harrington, TG Urbano, SA Bhide, C Clark, ... Lancet Oncol 12 (2), 127-136, 2011 | 78 | 2011 |
| A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer T Guerrero Urbano, CH Clark, VN Hansen, EJ Adams, R A’Hern, EA Miles, ... Radiotherapy and Oncology 85 (1), 36-41, 2007 | 74 | 2007 |
| Dosimetry audit for a multi-centre IMRT head and neck trial CH Clark, VN Hansen, H Chantler, C Edwards, HV James, G Webster, ... Radiotherapy and Oncology 93 (1), 102-108, 2009 | 73 | 2009 |
| A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy CH Clark, M Hussein, Y Tsang, R Thomas, D Wilkinson, G Bass, J Snaith, ... Radiotherapy and Oncology 113 (2), 272-278, 2014 | 72 | 2014 |
| Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines R Mir, SM Kelly, Y Xiao, A Moore, CH Clark, E Clementel, C Corning, ... Radiotherapy and Oncology 150, 30-39, 2020 | 68 | 2020 |
| Radiation therapy quality assurance in clinical trials–Global Harmonisation Group C Melidis, WR Bosch, J Izewska, E Fidarova, E Zubizarreta, S Ishikura, ... Radiotherapy and Oncology 111 (3), 327-329, 2014 | 68 | 2014 |
| Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study TG Urbano, CH Clark, VN Hansen, EJ Adams, EA Miles, H Mc Nair, ... Radiotherapy and Oncology 85 (1), 58-63, 2007 | 66 | 2007 |
Andrew NisbetDepartment of Medical Physics & Biomedical Engineering, University College LondonVerified email at ucl.ac.uk
